Skip to main content
Log in

Role for glucose transporter 1 protein in human breast cancer

  • Article
  • Published:
Pathology & Oncology Research

Abstract

Glycolysis is increased in cancer cells compared with normal cells. It has been shown that glucose enters cells via a family of five functional glucose transporters (GLUT). However, GLUT expression appears to be altered in human breast cancer, which may serve as a selective advantage and facilitate the metastatic potential of these cells. The relationship of GLUT isoform expression and breast cancer cell invasiveness has not been adequately addressed. Thus, the purpose of this study was to investigate whether an association exists between GLUT expression and human breast cancer cell invasiveness. Invasiveness of the human breast cancer lines MCF-7, MDA-MB-435 and MDA-MB-231 was measured using anin vitro assay and compared with cellular GLUT isoform expression, assessed by Western blot analysis and verified by immunohistochemistry in a poorly differentiated human ductal breast cancer. Cell surface GLUT-1 expression was associated with the invasive ability of MCF-7 (2.0 ± 0.02%), MDA-MB-435 (6.4 ±0.4%), and MDA-MB-231 (19.3 ± 2.0%). However, GLUT-2 and GLUT-5 were inversely associated with invasiveness; GLUT-3 expression was variable; and GLUT-4 was undetected. In a poorly differentiated human ductal breast cancer,in situ GLUT-1 staining was intense. GLUT-1 expression was associated with the in vitro invasive ability of human breast cancer cells which was validatedin situ. If this relationship is found to exist in a larger number of human breast cancer tissues, it may be possible to develop diagnostic and therapeutic strategies based on targeted GLUT isoform expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bashan N, Burdett E, Guma A, et al Mechanisms of adaptation of glucose transporters to changes in the oxidative chain of muscle and fat cells. Am J Physiol 264:C430–40, 1993.

    PubMed  CAS  Google Scholar 

  2. Beckner ME, Stracke ML, Liotta LA, Schiffmann E: Glycolysis as primary energy source in tumor cell chemotaxis. J Natl Cancer Inst 82:1836–1840, 1990.

    Article  PubMed  CAS  Google Scholar 

  3. Bell GI, Burant CF, Takeda J, Gould GW: Structure and function of mammalian facilitative sugar transporters. J Biol Chem 268:19161–19164, 1993.

    PubMed  CAS  Google Scholar 

  4. Birnbaum MJ, Haspel HC, Rosen OM: Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science 235:1495–1498, 1987.

    Article  PubMed  CAS  Google Scholar 

  5. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248–55, 1976.

    Article  PubMed  CAS  Google Scholar 

  6. Brown RS, Wahl RL: Overexpression of GLUT-1 glucose transporter in human breast cancer. Cancer Res 72:2979–2985, 1993.

    CAS  Google Scholar 

  7. Chan J, Aoki C, Pickel VM: Optimization of differential immu-nogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neu-rosci Methods 33:113–27, 1990.

    Article  CAS  Google Scholar 

  8. Clavo AC, Brown RS, Wahl RL: Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med 36:1625–1632, 1995.

    PubMed  CAS  Google Scholar 

  9. Danscher G: Localization of gold in biological tissue. A photochemical method for light and electron microscopy. Histoche-mistry 71:81–8, 1981.

    Article  CAS  Google Scholar 

  10. Flier JS, Mueckler MM, Usher P, Lodish HF: Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235:1492–1495, 1987.

    Article  PubMed  CAS  Google Scholar 

  11. Godwin AK, Lieberman MW: Elevation of glucose transporter, c-myc, and transin RNA levels by Ha-rasT24 is independent of its effect on the cell cycle. Mol Carcinog 4:275–85, 1991.

    Article  PubMed  CAS  Google Scholar 

  12. Loike JD, Cao L, Brett J, et al: Hypoxia induces glucose transporter expression in endothelial cells. Am J Physiol 263:C326–33, 1992.

    PubMed  CAS  Google Scholar 

  13. Mitsumoto Y, Burdett E, Gant A, Klip A: Differential expression of the GLUT1 and GLUT4 glucose transporters during differentiation of L6 muscle cells. Biochem Biophy Res Commun 175:652–659, 1991.

    Article  CAS  Google Scholar 

  14. Mueckler M: Facilitative glucose transporters. Eur J Biochem 219:713–25, 1994.

    Article  PubMed  CAS  Google Scholar 

  15. Pessin JE, Bell GI: Mammalian facilitative glucose transporter family: Structure and molecular regulation. Annu Rev Physiol 54:911–930, 1992.

    Article  PubMed  CAS  Google Scholar 

  16. Postic C, Leturque A, Printz RL, et al: Development and regulation of glucose transporter and hexokinase expression in rat. Am J Physiol 266:E548-E559, 1994.

    PubMed  CAS  Google Scholar 

  17. Salter DW, Baldwin SA, Lienhard GE, Weber MJ: Proteins anti-genically related to the human erythrocyte glucose transporter in normal and Rous sarcoma virus-transformed chicken embryo fibroblasts. Proc Natl Acad Sci USA 79:1540–1544, 1982.

    Article  PubMed  CAS  Google Scholar 

  18. Santalucia T, Camps M, Castello A, et al: Developmental regulation of GLUT-1 (erythroid/Hep G2) and GLUT-4 (Muscle/fat) Glucose transporter expression in rat heart, skeletal muscle and brown adipose tissue. Endocrinol 130:837–846, 1992.

    Article  CAS  Google Scholar 

  19. Seftor EA, Seftor REB, Hendrix MJC: Selection of invasive and metastatic subpopulations from a heterogeneous human melanoma cell line. BioTechniques 9:324–31, 1990.

    PubMed  CAS  Google Scholar 

  20. Seftor REB, Seftor EA, Stetler-Stevenson WG, Hendrix MJC: The 72 kDa Type IV Collagenase is modulated via differential expression of αvβ3 and α5 β1, integrins during human melanoma cell invasion. Cancer Res 53:3411–3415, 1993.

    PubMed  CAS  Google Scholar 

  21. Shepherd PR, Gould GW, Colville CA, et al Distribution of GLUT3 glucose transporter protein in human tissues. Biochem Biophy Res Commun 188:149–154, 1992.

    Article  CAS  Google Scholar 

  22. Sivitz WI, Lund DD, Yorek B, et al: Pretranslational regulation of two cardiac glucose transporters in rats exposed to hypobar-ic hypoxia. Am J Physiol 263:E562-E569, 1992.

    PubMed  CAS  Google Scholar 

  23. Studelska DR, Campbell C, Pang S, et al: Developmental expression of insulin-regulatable glucose transporter GLUT-4. Am J Physiol 263:E102–6, 1992.

    PubMed  CAS  Google Scholar 

  24. Thomas HM, Brant AM, Colville CA, et al: Tissue-specific expression of facilitative glucose transporters: a rationale. Biochem Soc Trans 20:538–542, 1992.

    PubMed  CAS  Google Scholar 

  25. Warburg O: On the origin of cancer cells. Science 123:309–314, 1956.

    Article  PubMed  CAS  Google Scholar 

  26. Younes M, Brown RW, Mody DR, et al: GLUT1 expression in human breast carcinoma: Correlation with known prognostic markers. Anticancer Res 15:2895–2898, 1995.

    PubMed  CAS  Google Scholar 

  27. Zamora-Leon SP, Golde DW, Concha II, et al: Expression of the fructose transporter GLUT5 in human breast cancer. Proc Natl Acad Sci USA 93:1847–1852, 1996.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maleah Grover-McKay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grover-McKay, M., Walsh, S.A., Seftor, E.A. et al. Role for glucose transporter 1 protein in human breast cancer. Pathol. Oncol. Res. 4, 115–120 (1998). https://doi.org/10.1007/BF02904704

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02904704

Key words

Navigation